1. Home
  2. RGEN vs OHI Comparison

RGEN vs OHI Comparison

Compare RGEN & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • OHI
  • Stock Information
  • Founded
  • RGEN 1981
  • OHI 1992
  • Country
  • RGEN United States
  • OHI United States
  • Employees
  • RGEN N/A
  • OHI N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • OHI Real Estate Investment Trusts
  • Sector
  • RGEN Health Care
  • OHI Real Estate
  • Exchange
  • RGEN Nasdaq
  • OHI Nasdaq
  • Market Cap
  • RGEN 8.2B
  • OHI 8.3B
  • IPO Year
  • RGEN N/A
  • OHI N/A
  • Fundamental
  • Price
  • RGEN $141.93
  • OHI $40.59
  • Analyst Decision
  • RGEN Buy
  • OHI Buy
  • Analyst Count
  • RGEN 10
  • OHI 12
  • Target Price
  • RGEN $188.38
  • OHI $34.73
  • AVG Volume (30 Days)
  • RGEN 926.2K
  • OHI 1.5M
  • Earning Date
  • RGEN 10-29-2024
  • OHI 10-31-2024
  • Dividend Yield
  • RGEN N/A
  • OHI 6.60%
  • EPS Growth
  • RGEN N/A
  • OHI 27.46
  • EPS
  • RGEN N/A
  • OHI 1.31
  • Revenue
  • RGEN $602,354,000.00
  • OHI $977,395,000.00
  • Revenue This Year
  • RGEN $0.08
  • OHI N/A
  • Revenue Next Year
  • RGEN $12.97
  • OHI $9.00
  • P/E Ratio
  • RGEN N/A
  • OHI $31.11
  • Revenue Growth
  • RGEN N/A
  • OHI 14.63
  • 52 Week Low
  • RGEN $110.45
  • OHI $27.53
  • 52 Week High
  • RGEN $211.13
  • OHI $40.59
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 43.03
  • OHI 75.41
  • Support Level
  • RGEN $139.41
  • OHI $39.75
  • Resistance Level
  • RGEN $150.72
  • OHI $40.37
  • Average True Range (ATR)
  • RGEN 5.29
  • OHI 0.58
  • MACD
  • RGEN -0.97
  • OHI 0.01
  • Stochastic Oscillator
  • RGEN 22.17
  • OHI 93.88

About RGEN Repligen Corporation

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.

About OHI Omega Healthcare Investors Inc.

Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).

Share on Social Networks: